Cavitation Technologies, Inc. Logo

Cavitation Technologies, Inc.

CVAT

(1.8)
Stock Price

0,02 USD

177.02% ROA

-57.37% ROE

5.5x PER

Market Cap.

2.416.465,00 USD

-38.54% DER

0% Yield

33.97% NPM

Cavitation Technologies, Inc. Stock Analysis

Cavitation Technologies, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cavitation Technologies, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (936.81%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

With a remarkably low PBV ratio (-3.57x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-9%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

5 ROA

The stock's ROA (-909.31%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Cavitation Technologies, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cavitation Technologies, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Cavitation Technologies, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cavitation Technologies, Inc. Revenue
Year Revenue Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 589.926 100%
2012 187.216 -215.1%
2013 1.259.623 85.14%
2014 1.855.707 32.12%
2015 489.255 -279.29%
2016 1.798.217 72.79%
2017 1.063.054 -69.16%
2018 1.303.000 18.41%
2019 1.090.000 -19.54%
2020 1.663.000 34.46%
2021 558.000 -198.03%
2022 1.665.000 66.49%
2023 433.000 -284.53%
2024 2.608.000 83.4%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cavitation Technologies, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 311.793 100%
2010 2.184.902 85.73%
2011 664.994 -228.56%
2012 152.002 -337.49%
2013 140.326 -8.32%
2014 40.820 -243.77%
2015 22.310 -82.97%
2016 29.371 24.04%
2017 27.105 -8.36%
2018 25.000 -8.42%
2019 25.000 0%
2020 18.000 -38.89%
2021 21.000 14.29%
2022 17.000 -23.53%
2023 3.000 -466.67%
2024 64.000 95.31%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cavitation Technologies, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 0
2007 52.200 100%
2008 13.000 -301.54%
2009 2.086.293 99.38%
2010 5.675.627 63.24%
2011 3.029.912 -87.32%
2012 1.720.315 -76.13%
2013 1.927.657 10.76%
2014 2.444.163 21.13%
2015 1.772.618 -37.88%
2016 1.214.561 -45.95%
2017 2.033.453 40.27%
2018 1.507.000 -34.93%
2019 1.719.000 12.33%
2020 1.469.000 -17.02%
2021 1.264.000 -16.22%
2022 1.728.000 26.85%
2023 1.195.000 -44.6%
2024 608.000 -96.55%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cavitation Technologies, Inc. EBITDA
Year EBITDA Growth
2006 -5.000
2007 -58.200 91.41%
2008 -19.000 -206.32%
2009 -2.390.874 99.21%
2010 -7.843.561 69.52%
2011 -3.175.001 -147.04%
2012 -1.566.138 -102.73%
2013 -696.600 -124.83%
2014 -648.753 -7.38%
2015 -1.289.146 49.68%
2016 492.906 361.54%
2017 -1.015.978 148.52%
2018 -401.000 -153.36%
2019 -682.000 41.2%
2020 243.000 380.66%
2021 -662.000 136.71%
2022 -169.000 -291.72%
2023 -2.031.000 91.68%
2024 1.476.000 237.6%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cavitation Technologies, Inc. Gross Profit
Year Gross Profit Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 498.782 100%
2012 146.652 -240.11%
2013 1.228.448 88.06%
2014 1.735.537 29.22%
2015 416.002 -317.19%
2016 1.676.712 75.19%
2017 993.613 -68.75%
2018 1.181.000 15.87%
2019 1.021.000 -15.67%
2020 1.623.000 37.09%
2021 538.000 -201.67%
2022 1.624.000 66.87%
2023 312.000 -420.51%
2024 2.148.000 85.47%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cavitation Technologies, Inc. Net Profit
Year Net Profit Growth
2006 -5.000
2007 -58.200 91.41%
2008 -19.000 -206.32%
2009 -2.495.991 99.24%
2010 -8.196.462 69.55%
2011 -3.295.428 -148.72%
2012 -1.928.128 -70.91%
2013 -988.126 -95.13%
2014 -2.184.487 54.77%
2015 -1.378.926 -58.42%
2016 432.780 418.62%
2017 -1.066.945 140.56%
2018 -250.000 -326.78%
2019 -723.000 65.42%
2020 128.000 664.84%
2021 -655.000 119.54%
2022 -934.000 29.87%
2023 -2.040.000 54.22%
2024 1.500.000 236%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cavitation Technologies, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cavitation Technologies, Inc. Free Cashflow
Year Free Cashflow Growth
2006 -5.000
2007 -51.200 90.23%
2008 -13.000 -293.85%
2009 -1.039.952 98.75%
2010 -1.213.548 14.3%
2011 -737.554 -64.54%
2012 -284.467 -159.28%
2013 588.362 148.35%
2014 -36.968 1691.54%
2015 -123.441 70.05%
2016 -821.169 84.97%
2017 -108.811 -654.67%
2018 396.000 127.48%
2019 -296.000 233.78%
2020 6.000 5033.33%
2021 -378.000 101.59%
2022 -484.000 21.9%
2023 -423.000 -14.42%
2024 7.000 6142.86%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cavitation Technologies, Inc. Operating Cashflow
Year Operating Cashflow Growth
2006 -5.000
2007 -51.200 90.23%
2008 -13.000 -293.85%
2009 -995.292 98.69%
2010 -1.025.761 2.97%
2011 -614.188 -67.01%
2012 -230.893 -166.01%
2013 708.907 132.57%
2014 31.910 -2121.58%
2015 -100.691 131.69%
2016 -759.604 86.74%
2017 -53.311 -1324.85%
2018 396.000 113.46%
2019 -280.000 241.43%
2020 56.000 600%
2021 -250.000 122.4%
2022 -484.000 48.35%
2023 -423.000 -14.42%
2024 7.000 6142.86%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cavitation Technologies, Inc. Capital Expenditure
Year Capital Expenditure Growth
2006 0
2007 0 0%
2008 0 0%
2009 44.660 100%
2010 187.787 76.22%
2011 123.366 -52.22%
2012 53.574 -130.27%
2013 120.545 55.56%
2014 68.878 -75.01%
2015 22.750 -202.76%
2016 61.565 63.05%
2017 55.500 -10.93%
2018 0 0%
2019 16.000 100%
2020 50.000 68%
2021 128.000 60.94%
2022 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cavitation Technologies, Inc. Equity
Year Equity Growth
2006 46.000
2007 -6.200 841.94%
2008 -19.200 67.71%
2009 -1.165.900 98.35%
2010 -759.644 -53.48%
2011 -740.297 -2.61%
2012 -1.963.972 62.31%
2013 -2.126.530 7.64%
2014 -382.024 -456.65%
2015 -1.075.555 64.48%
2016 -642.775 -67.33%
2017 -1.144.720 43.85%
2018 -545.000 -110.04%
2019 -819.000 33.46%
2020 -490.000 -67.14%
2021 -411.000 -19.22%
2022 1.036.000 139.67%
2023 -919.000 212.73%
2024 -480.000 -91.46%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cavitation Technologies, Inc. Assets
Year Assets Growth
2006 50.000
2007 0 0%
2008 0 0%
2009 79.632 100%
2010 246.500 67.69%
2011 397.588 38%
2012 570.432 30.3%
2013 598.719 4.72%
2014 1.557.220 61.55%
2015 1.761.202 11.58%
2016 959.684 -83.52%
2017 844.731 -13.61%
2018 1.079.000 21.71%
2019 1.021.000 -5.68%
2020 1.304.000 21.7%
2021 1.831.000 28.78%
2022 1.871.000 2.14%
2023 143.000 -1208.39%
2024 248.000 42.34%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cavitation Technologies, Inc. Liabilities
Year Liabilities Growth
2006 4.000
2007 6.200 35.48%
2008 19.200 67.71%
2009 1.245.532 98.46%
2010 1.006.144 -23.79%
2011 1.137.885 11.58%
2012 2.534.404 55.1%
2013 2.725.249 7%
2014 1.939.244 -40.53%
2015 2.836.757 31.64%
2016 1.602.459 -77.03%
2017 1.989.451 19.45%
2018 1.624.000 -22.5%
2019 1.840.000 11.74%
2020 1.794.000 -2.56%
2021 2.242.000 19.98%
2022 835.000 -168.5%
2023 1.062.000 21.37%
2024 728.000 -45.88%

Cavitation Technologies, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0
Price to Earning Ratio
5.5x
Price To Sales Ratio
1.77x
POCF Ratio
14.05
PFCF Ratio
14.05
Price to Book Ratio
-5.03
EV to Sales
1.78
EV Over EBITDA
5.53
EV to Operating CashFlow
14.08
EV to FreeCashFlow
14.08
Earnings Yield
0.18
FreeCashFlow Yield
0.07
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.01
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
0
Income Quality
0.39
ROE
-0.48
Return On Assets
6.01
Return On Capital Employed
-0.8
Net Income per EBT
1
EBT Per Ebit
1
Ebit per Revenue
0.34
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0.52
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.89
Operating Profit Margin
0.34
Pretax Profit Margin
0.34
Net Profit Margin
0.34

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-1.49
Return on Tangible Assets
1.77
Days Sales Outstanding
0
Days Payables Outstanding
301.83
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
1.21
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0
Shareholders Equity per Share
-0
Interest Debt per Share
0
Debt to Equity
-0.39
Debt to Assets
0.75
Net Debt to EBITDA
0.01
Current Ratio
0.33
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-361000
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cavitation Technologies, Inc. Dividends
Year Dividends Growth

Cavitation Technologies, Inc. Profile

About Cavitation Technologies, Inc.

Cavitation Technologies, Inc. develops, patents, and commercializes proprietary technology for use in the processing of various industrial and consumer-oriented fluids in the United States. The company offers Nano Reactor and Nano Neutralization Systems for refining vegetable oils, such as soybean, rapeseed, canola, and palm oil. It also develops other technology-based systems for various markets, such as renewable fuels, water treatment, wines and spirits enhancement, algae oil extraction, water-oil emulsions, and crude oil yield enhancement. The company was founded in 2007 and is headquartered in Chatsworth, California.

CEO
Mr. Naum D. Voloshin
Employee
2
Address
10019 Canoga Avenue
Chatsworth, 91311

Cavitation Technologies, Inc. Executives & BODs

Cavitation Technologies, Inc. Executives & BODs
# Name Age
1 Mr. Maxim Promtov
Head of Research and Director of Research & Development
70
2 Mr. Naum D. Voloshin
President, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer, Secretary & Director
70
3 Mr. Roman Gordon
Co-Founder & Global Technology Manager
70

Cavitation Technologies, Inc. Competitors